Timothy B. Niewold, MD, started his involvement with the Foundation early in his career when his mentor told him about its grant opportunities and encouraged him to apply. He feels lucky to have had the Foundation’s support as early as he did.
With more than 150 exhibiting companies and organizations, the Exhibit Hall is the place to discover the newest products and services in the field of rheumatology!
Guided poster tours allow scientific attendees to ask questions and gain insights from some of the best-known rheumatology leaders. Tours are complimentary, but registration is required and is limited to scientific attendees.
Jacquelyn Maher, MD, will discuss the nexus of rheumatology and nonalcoholic steatohepatitis (NASH) during a clinical symposium on Monday morning.
Most rheumatologists don’t focus too much on vascular biology — except on those days, most often in winter, when they encounter the patients whose fingers have changed color. “The vascular system is an essential and highly integrated system in the body, but it is spread around several different disciplines,” said Nicholas Flavahan, PhD.
Dr. Chopra will explore the developing problem of chikungunya-caused arthropathy during the clinical symposium this morning. Dr. Chopra experienced chikungunya during a 2006 epidemic in India.
Next year, rheumatologists in community practice will be eligible for a new award from the Rheumatology Research Foundation. Thanks to a $1 million commitment, the Norman B. Gaylis, MD, Research Award for Rheumatologists in Community Practice will provide them support to test theories based on their own observations.
“The agents that target TNF or its receptors are highly efficacious in treating all sorts of autoimmune diseases,” said Michael Croft, PhD. “But TNF and its receptors are just one set of molecules in a large family of related receptors. All of the proteins in this superfamily play significant roles in autoimmune disease.”
As physicians, we have made a commitment to lifelong learning and keeping up new advances in our field. However, the realities of busy clinical practice make incorporating MOC and brushing up on medical knowledge difficult. The ACR’s CARE modules can help.
The RISE Registry is a Qualified Clinical Data Registry (QCDR), which is a CMS-approved registry that collects data for the purpose of patient and disease tracking to foster improvement in the quality of care provided to patients.